Redwood Wealth Management Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Redwood Wealth Management Group's PFE Position: Q1 2026 in Review
Redwood Wealth Management Group reduced its Pfizer (PFE) stake by 6.4% in Q1 2026, selling an estimated $31.3K and leaving 17,262 shares worth $485K. The position accounts for 0.21% of the portfolio, ranked #93.
Redwood Wealth Management Group first reported a position in PFE in Q4 2022 and has held it in 14 quarters since. The position peaked at $908K in Q4 2022. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Redwood Wealth Management Group held 17,262 shares of Pfizer worth $485K as of Q1 2026.
- Redwood Wealth Management Group sold 1,174 Pfizer shares in Q1 2026, an estimated $31.3K.
- Pfizer made up 0.21% of Redwood Wealth Management Group's portfolio in Q1 2026, its #93 holding.
- Redwood Wealth Management Group first reported a position in Pfizer in Q4 2022 and has held it in 14 quarters since.
- Redwood Wealth Management Group's Pfizer position peaked at $908K in Q4 2022.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Redwood Wealth Management Group's 13F filing for Q1 2026, filed 24 Apr 2026.